Junhun K. Cho

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications

Danburstotug, an anti-PD-L1 antibody, in relapsed/refractory extra-nodal natural killer/T-cell lymphoma: The phase 2 DISTINKT study.

Danburstotug, an anti-PD-L1 antibody, in relapsed/refractory extra-nodal natural killer/T-cell lymphoma: The phase 2 DISTINKT study.

Journal: British journal of haematology
Published: April 08, 2026

Clinical heterogeneity of primary cutaneous γδ T-cell lymphoma: a 20-year single-institution experience.

Clinical heterogeneity of primary cutaneous γδ T-cell lymphoma: a 20-year single-institution experience.

Journal: Blood research
Published: March 16, 2026

International Consensus Guidelines for Diagnostic Criteria and Checklist for Future Studies for Minimally Invasive Carcinoma ex Pleomorphic Adenoma: An HN CLEAR Initiative.

International Consensus Guidelines for Diagnostic Criteria and Checklist for Future Studies for Minimally Invasive Carcinoma ex Pleomorphic Adenoma: An HN CLEAR Initiative.

Journal: Head and neck pathology
Published: November 19, 2025

Long-term outcomes of 40 Gy CCRT with weekly cisplatin and systemic chemotherapy in limited-stage ENKTL.

Long-term outcomes of 40 Gy CCRT with weekly cisplatin and systemic chemotherapy in limited-stage ENKTL.

Journal: Blood advances
Published: November 18, 2025

Identification of a neoplastic Tfh-like cellular subset in a mouse model of angioimmunoblastic T cell lymphoma.

Identification of a neoplastic Tfh-like cellular subset in a mouse model of angioimmunoblastic T cell lymphoma.

Journal: Frontiers in oncology
Published: September 29, 2025

Real-world use of polatuzumab vedotin combined with bendamustine and rituximab for patients with relapsed or refractory large B-cell lymphoma.

Real-world use of polatuzumab vedotin combined with bendamustine and rituximab for patients with relapsed or refractory large B-cell lymphoma.

Journal: The Korean journal of internal medicine
Published: August 18, 2025

Imaging of Pulmonary Malignant Lymphoproliferative Disorders.

Imaging of Pulmonary Malignant Lymphoproliferative Disorders.

Journal: Seminars in ultrasound, CT, and MR
Published: June 25, 2025

Aggressive natural killer cell leukemia therapy in the L-asparaginase era: why are we failing?

Aggressive natural killer cell leukemia therapy in the L-asparaginase era: why are we failing?

Journal: Blood research
Published: June 09, 2025

Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B-cell lymphoma.

Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B-cell lymphoma.

Journal: Blood advances
Published: April 15, 2025

The patterns of systemic metastasis in major salivary gland cancer and therapeutic implications.

The patterns of systemic metastasis in major salivary gland cancer and therapeutic implications.

Journal: Oral oncology
Published: March 09, 2025

Determination of the appropriate chemotherapy for patients aged 80 years or older with diffuse large B cell lymphoma.

Determination of the appropriate chemotherapy for patients aged 80 years or older with diffuse large B cell lymphoma.

Journal: Leukemia & lymphoma
Published: March 03, 2025

Real-world data analysis of survival outcomes of patients with primary mediastinal large B-cell lymphoma treated with immunochemotherapy: the role of consolidative radiation therapy.

Real-world data analysis of survival outcomes of patients with primary mediastinal large B-cell lymphoma treated with immunochemotherapy: the role of consolidative radiation therapy.

Journal: Blood research
Published: January 22, 2025
Showing 1-12 of 120

Last Updated: 09/26/2026